Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: Cyclomedica Ireland Ltd, Ulysses House (Third floor), Foley Street, Dublin 1, Ireland
Pharmacotherapeutic group: Diagnostic radiopharmaceuticals; Technetium (99mTc), inhalants
ATC code: V09EA02
In the concentrations used for diagnostic examinations, Technegas is an inert suspension and has no pharmacological effect.
After inhalation, Technegas is absorbed on the walls of pulmonary alveoli and remains in the lungs. There is no intra vascular clearance and elimination of radioactivity is by the physical decay of the technetium-99m.
Part of the carbon micro-particles may be retained in the upper and central airways and is greater in patients with airway obstruction. These particles are cleared by ciliary action and, after swallowing, are eliminated through the gastro-intestinal tract without absorption.
Toxicological data on PULMOTEC are not available.
A single administration of inhaled radioactivity of 5.5 MBq in a rat was well tolerated with most of the radioactivity inhaled found in the lung.
Studies of oral administration of solution of Technegas in rats showed that the radioactivity remained almost exclusively in the gastro-intestinal tract.
No study of effects on reproductive functions, of a mutagenic and carcinogenic potential has been carried out.
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
